Biogen Idec, Inc. (BIIB) Tops Q3 Adj-EPS by 8c
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Join SI Premium – FREE
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q3 EPS of $1.61, ex-items, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.27 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
